102 related articles for article (PubMed ID: 8289994)
1. Effects of an angiotensin II receptor antagonist on the progression of renal failure in hyperlipidemic Imai rats.
Sakemi T; Baba N
Nephron; 1993; 65(3):426-32. PubMed ID: 8289994
[TBL] [Abstract][Full Text] [Related]
2. Effects of antihypertensive drugs on the progress of renal failure in hyperlipidemic Imai rats.
Sakemi T; Baba N
Nephron; 1993; 63(3):323-9. PubMed ID: 8446271
[TBL] [Abstract][Full Text] [Related]
3. Effects of chronic treatment with angiotensin converting enzyme inhibitor or an angiotensin receptor antagonist in two-kidney, one-clip hypertensive rats.
Imamura A; Mackenzie HS; Lacy ER; Hutchison FN; Fitzgibbon WR; Ploth DW
Kidney Int; 1995 May; 47(5):1394-402. PubMed ID: 7637269
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin-converting enzyme inhibition attenuates hypercholesterolemia and glomerular injury in hyperlipidemic Imai rats.
Sakemi T; Baba N; Yoshikawa Y
Nephron; 1992; 62(3):315-21. PubMed ID: 1436345
[TBL] [Abstract][Full Text] [Related]
5. Effect of candesartan cilexetil (TCV-116) in rats with chronic renal failure.
Noda M; Matsuo T; Fukuda R; Ohta M; Nagano H; Shibouta Y; Naka T; Nishikawa K; Imura Y
Kidney Int; 1999 Sep; 56(3):898-909. PubMed ID: 10469358
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II receptor blockade improves renal function in rats with reduced renal mass.
Pollock DM; Divish BJ; Polakowski JS; Opgenorth TJ
J Pharmacol Exp Ther; 1993 Nov; 267(2):657-63. PubMed ID: 8246138
[TBL] [Abstract][Full Text] [Related]
7. Comparison of systemic and regional hemodynamic effects of a diuretic, an angiotensin II receptor antagonist, and an angiotensin-converting enzyme inhibitor in conscious renovascular hypertensive rats.
Wang YX; Gavras I; Wierzba T; Gavras H
J Lab Clin Med; 1992 Mar; 119(3):267-72. PubMed ID: 1541876
[TBL] [Abstract][Full Text] [Related]
8. Dup 753 prevents the development of puromycin aminonucleoside-induced nephrosis.
Yayama K; Kawao M; Tujii H; Itoh N; Okamoto H
Eur J Pharmacol; 1993 May; 236(2):337-8. PubMed ID: 8319760
[TBL] [Abstract][Full Text] [Related]
9. Effect of ANG II receptor antagonist on albuminuria and renal function in passive Heymann nephritis.
Hutchinson FN; Webster SK
Am J Physiol; 1992 Aug; 263(2 Pt 2):F311-8. PubMed ID: 1510124
[TBL] [Abstract][Full Text] [Related]
10. The role of the renin-angiotensin system in cisplatin nephrotoxicity.
Deegan PM; Nolan C; Ryan MP; Basinger MA; Jones MM; Hande KR
Ren Fail; 1995 Nov; 17(6):665-74. PubMed ID: 8771239
[TBL] [Abstract][Full Text] [Related]
11. [Renal protective effect of angiotensin II receptor antagonist on growth hormone-treated nephrotic rats].
Li S; Cao B; Feng QH; Li XZ
Zhonghua Er Ke Za Zhi; 2003 Nov; 41(11):817-21. PubMed ID: 14728886
[TBL] [Abstract][Full Text] [Related]
12. Effect of sodium chloride, enalapril, and losartan on the development of polycystic kidney disease in Han:SPRD rats.
Keith DS; Torres VE; Johnson CM; Holley KE
Am J Kidney Dis; 1994 Sep; 24(3):491-8. PubMed ID: 8079975
[TBL] [Abstract][Full Text] [Related]
13. The antihypertensive effect of the angiotensin II receptor antagonist DuP 753 may not be due solely to angiotensin II receptor antagonism.
Ohlstein EH; Gellai M; Brooks DP; Vickery L; Jugus J; Sulpizio A; Ruffolo RR; Weinstock J; Edwards RM
J Pharmacol Exp Ther; 1992 Aug; 262(2):595-601. PubMed ID: 1501114
[TBL] [Abstract][Full Text] [Related]
14. Protective effects of ME3221 on hypertensive complications and lifespan in salt-loaded stroke-prone spontaneously hypertensive rats.
Nagura J; Yamamoto M; Hui C; Yasuda S; Hachisu M; Konno F
Clin Exp Pharmacol Physiol; 1996 Mar; 23(3):229-35. PubMed ID: 8934613
[TBL] [Abstract][Full Text] [Related]
15. Renoprotective mechanisms of angiotensin II antagonism in experimental chronic renal failure.
Uhlenius N; Miettinen A; Vuolteenaho O; Tikkanen I
Kidney Blood Press Res; 2002; 25(2):71-9. PubMed ID: 12077487
[TBL] [Abstract][Full Text] [Related]
16. Antiproteinuric effect of KD3-671, an angiotensin II type 1 receptor antagonist, in rats with accelerated passive Heymann nephritis.
Nagamatsu T; Nagao T; Hayashi K; Suzuki Y
Jpn J Pharmacol; 2002 Feb; 88(2):213-6. PubMed ID: 11928723
[TBL] [Abstract][Full Text] [Related]
17. Role of angiotensin II in cerebrovascular and renal damage in deoxycorticosterone acetate-salt hypertensive rats.
Wada T; Kanagawa R; Ishimura Y; Inada Y; Nishikawa K
J Hypertens; 1995 Jan; 13(1):113-22. PubMed ID: 7759841
[TBL] [Abstract][Full Text] [Related]
18. Stroke prevention by losartan in stroke-prone spontaneously hypertensive rats.
Stier CT; Adler LA; Levine S; Chander PN
J Hypertens Suppl; 1993 Apr; 11(3):S37-42. PubMed ID: 8315518
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass.
Lafayette RA; Mayer G; Park SK; Meyer TW
J Clin Invest; 1992 Sep; 90(3):766-71. PubMed ID: 1522231
[TBL] [Abstract][Full Text] [Related]
20. Renoprotective effect of small doses of losartan and enalapril in patients with primary glomerulonephritis. Short-term observation.
Tylicki L; Rutkowski P; Renke M; Rutkowski B
Am J Nephrol; 2002; 22(4):356-62. PubMed ID: 12169868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
